Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure

Curr Heart Fail Rep. 2019 Dec;16(6):304-314. doi: 10.1007/s11897-019-00442-1.

Abstract

Background: Identifying readmission predictors in heart failure (HF) patients may help guide preventative efforts and save costs. We aimed to identify 15- and 30-day readmission predictors due to cardiovascular reasons.

Methods and results: A total of 1831 patients with acute HF admission were prospectively followed during a year. Patient-associated variables were gathered at admission/discharge and events during follow-up. A multivariate Fine and Gray competing risk regression model and a cumulative incidence function were used to identify predictors and build a risk score model for 15- and 30-day readmission. The 15- and 30-day readmission rates due to cardiovascular reasons were 7.1% and 13.9%. Previous acute myocardial infarction, congestive signs at discharge, and length of stay > 9 days were predictors of 15- and 30-day readmission, while much weight loss and large NT-ProBNP reduction were protective factors. The NT-ProBNP reduction was larger at 30 days (> 55%) vs 15 days (> 40%) to protect from readmission. Glomerular filtration rate at discharge < 60 mL/min/1.73m2 and > 1 previous admissions due to HF were predictors of 30-day readmission, while first post-discharge control at an HF unit was a protective factor.

Conclusions: Previous identified factors for early readmission were confirmed. The NT-ProBNP reduction should be increased (> 55%) to protect from 30-day readmission.

Keywords: Heart failure; NT-ProBNP; Predictive factors; Readmission.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Female
  • Heart Failure / therapy*
  • Hospitalization
  • Humans
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • Natriuretic Peptide, C-Type / blood
  • Patient Readmission / statistics & numerical data*
  • Predictive Value of Tests
  • Prospective Studies
  • Risk Assessment / methods
  • Risk Factors
  • Weight Loss

Substances

  • Biomarkers
  • amino-terminal pro-C-type natriuretic peptide, human
  • Natriuretic Peptide, C-Type